A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production

Clinical trial NCT03198676 · COMPLETED

Trial details

NCT number

NCT03198676

Sponsor

Prep Biopharm Limited

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-05-08

Primary completion

2017-05-24

Enrollment

20

View on ClinicalTrials.gov